Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1081 entries
Sorted by: Best Match Show Resources per page
Peptide Vaccines for Hypertension and Diabetes Mellitus.

Vaccines

Nakagami H, Koriyama H, Morishita R.
PMID: 26344893
Vaccines (Basel). 2014 Nov 26;2(4):832-40. doi: 10.3390/vaccines2040832.

Vaccines are commonly used as a preventive medicine for infectious diseases worldwide; however, the trial for an amyloid beta vaccine against Alzheimer's disease will open a new concept in vaccination. In case of therapeutic vaccines for cancer, their targets...

Cite
Nakagami H, Koriyama H, Morishita R. Peptide Vaccines for Hypertension and Diabetes Mellitus. Vaccines (Basel). 2014;2(4):832-40doi: 10.3390/vaccines2040832.
Nakagami, H., Koriyama, H., & Morishita, R. (2014). Peptide Vaccines for Hypertension and Diabetes Mellitus. Vaccines, 2(4), 832-40. https://doi.org/10.3390/vaccines2040832
Nakagami, Hironori, et al. "Peptide Vaccines for Hypertension and Diabetes Mellitus." Vaccines vol. 2,4 (2014): 832-40. doi: https://doi.org/10.3390/vaccines2040832
Nakagami H, Koriyama H, Morishita R. Peptide Vaccines for Hypertension and Diabetes Mellitus. Vaccines (Basel). 2014 Nov 26;2(4):832-40. doi: 10.3390/vaccines2040832. PMID: 26344893; PMCID: PMC4494253.
Copy Download .nbib Format: NLM
SU-E-I-62: Investigation of Dominant Factors Affecting Fatigue in Image Reading of Radiologists.

Medical physics

Ikushima Y, Yabuuchi H, Honda H, Morishita J.
PMID: 28517642
Med Phys. 2012 Jun;39(6):3639. doi: 10.1118/1.4734778.

PURPOSE: To investigate dominant factors affecting fatigue in image reading of radiologists.METHODS: Two kinds of fatigue were assessed in this study. One was fatigue in the central nervous system evaluated by the critical fusion frequency (CFF). The other was...

Cite
Ikushima Y, Yabuuchi H, Honda H, et al. SU-E-I-62: Investigation of Dominant Factors Affecting Fatigue in Image Reading of Radiologists. Med Phys. 2012;39(6):3639doi: 10.1118/1.4734778.
Ikushima, Y., Yabuuchi, H., Honda, H., & Morishita, J. (2012). SU-E-I-62: Investigation of Dominant Factors Affecting Fatigue in Image Reading of Radiologists. Medical physics, 39(6), 3639. https://doi.org/10.1118/1.4734778
Ikushima, Y, et al. "SU-E-I-62: Investigation of Dominant Factors Affecting Fatigue in Image Reading of Radiologists." Medical physics vol. 39,6 (2012): 3639. doi: https://doi.org/10.1118/1.4734778
Ikushima Y, Yabuuchi H, Honda H, Morishita J. SU-E-I-62: Investigation of Dominant Factors Affecting Fatigue in Image Reading of Radiologists. Med Phys. 2012 Jun;39(6):3639. doi: 10.1118/1.4734778. PMID: 28517642.
Copy Download .nbib Format: NLM
Efficacy and safety of oxaliplatin, bevacizumab and oral S-1 for advanced recurrent colorectal cancer.

Molecular and clinical oncology

Suzuki S, Shimazaki J, Morishita K, Koike N, Harada N, Hayashi T, Suzuki M.
PMID: 27699032
Mol Clin Oncol. 2016 Oct;5(4):391-394. doi: 10.3892/mco.2016.977. Epub 2016 Aug 04.

The aim of this study was to evaluate the efficacy and safety of co-administration of oral S-1 and oxaliplatin (SOX) in combination with bevacizumab (bev) in patients with advanced recurrent colorectal cancer. A retrospective study of 36 patients with...

Cite
Suzuki S, Shimazaki J, Morishita K, et al. Efficacy and safety of oxaliplatin, bevacizumab and oral S-1 for advanced recurrent colorectal cancer. Mol Clin Oncol. 2016;5(4):391-394doi: 10.3892/mco.2016.977.
Suzuki, S., Shimazaki, J., Morishita, K., Koike, N., Harada, N., Hayashi, T., & Suzuki, M. (2016). Efficacy and safety of oxaliplatin, bevacizumab and oral S-1 for advanced recurrent colorectal cancer. Molecular and clinical oncology, 5(4), 391-394. https://doi.org/10.3892/mco.2016.977
Suzuki, Shuji, et al. "Efficacy and safety of oxaliplatin, bevacizumab and oral S-1 for advanced recurrent colorectal cancer." Molecular and clinical oncology vol. 5,4 (2016): 391-394. doi: https://doi.org/10.3892/mco.2016.977
Suzuki S, Shimazaki J, Morishita K, Koike N, Harada N, Hayashi T, Suzuki M. Efficacy and safety of oxaliplatin, bevacizumab and oral S-1 for advanced recurrent colorectal cancer. Mol Clin Oncol. 2016 Oct;5(4):391-394. doi: 10.3892/mco.2016.977. Epub 2016 Aug 04. PMID: 27699032; PMCID: PMC5038216.
Copy Download .nbib Format: NLM
SU-E-I-59: Investigation of the Usefulness of a Standard Deviation and Mammary Gland Density as Indexes for Mammogram Classification.

Medical physics

Takarabe S, Yabuuchi H, Morishita J.
PMID: 28517625
Med Phys. 2012 Jun;39(6):3638. doi: 10.1118/1.4734775.

PURPOSE: To investigate the usefulness of the standard deviation of pixel values in a whole mammary glands region and the percentage of a high- density mammary glands region to a whole mammary glands region as features for classification of...

Cite
Takarabe S, Yabuuchi H, Morishita J. SU-E-I-59: Investigation of the Usefulness of a Standard Deviation and Mammary Gland Density as Indexes for Mammogram Classification. Med Phys. 2012;39(6):3638doi: 10.1118/1.4734775.
Takarabe, S., Yabuuchi, H., & Morishita, J. (2012). SU-E-I-59: Investigation of the Usefulness of a Standard Deviation and Mammary Gland Density as Indexes for Mammogram Classification. Medical physics, 39(6), 3638. https://doi.org/10.1118/1.4734775
Takarabe, S, et al. "SU-E-I-59: Investigation of the Usefulness of a Standard Deviation and Mammary Gland Density as Indexes for Mammogram Classification." Medical physics vol. 39,6 (2012): 3638. doi: https://doi.org/10.1118/1.4734775
Takarabe S, Yabuuchi H, Morishita J. SU-E-I-59: Investigation of the Usefulness of a Standard Deviation and Mammary Gland Density as Indexes for Mammogram Classification. Med Phys. 2012 Jun;39(6):3638. doi: 10.1118/1.4734775. PMID: 28517625.
Copy Download .nbib Format: NLM
A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia.

Transplantation direct

Shigematsu A, Ozawa Y, Onizuka M, Fujisawa S, Suzuki R, Atsuta Y, Hatanaka K, Masuko M, Ito T, Kobayashi N, Kato J, Miyamura K, Fukuda T, Morishima Y, Imamura M.
PMID: 27500214
Transplant Direct. 2015 Mar 13;1(2):e8. doi: 10.1097/TXD.0000000000000514. eCollection 2015 Mar.

UNLABELLED: Prognosis for adult patients with acute lymphoblastic leukemia (ALL) has been reported to be approximately 35% to 50%, even after allogeneic stem cell transplantation (allo-SCT). We previously reported retrospective analyses of a conditioning regimen of medium-dose etoposide, cyclophosphamide...

Cite
Shigematsu A, Ozawa Y, Onizuka M, et al. A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia. Transplant Direct. 2015;1(2):e8doi: 10.1097/TXD.0000000000000514.
Shigematsu, A., Ozawa, Y., Onizuka, M., Fujisawa, S., Suzuki, R., Atsuta, Y., Hatanaka, K., Masuko, M., Ito, T., Kobayashi, N., Kato, J., Miyamura, K., Fukuda, T., Morishima, Y., & Imamura, M. (2015). A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia. Transplantation direct, 1(2), e8. https://doi.org/10.1097/TXD.0000000000000514
Shigematsu, Akio, et al. "A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia." Transplantation direct vol. 1,2 (2015): e8. doi: https://doi.org/10.1097/TXD.0000000000000514
Shigematsu A, Ozawa Y, Onizuka M, Fujisawa S, Suzuki R, Atsuta Y, Hatanaka K, Masuko M, Ito T, Kobayashi N, Kato J, Miyamura K, Fukuda T, Morishima Y, Imamura M. A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia. Transplant Direct. 2015 Mar 13;1(2):e8. doi: 10.1097/TXD.0000000000000514. eCollection 2015 Mar. PMID: 27500214; PMCID: PMC4946459.
Copy Download .nbib Format: NLM
HS-142-1, a Novel Non-peptide Antagonist for Atrial Natriuretic Peptide Receptor, Selectively Inhibits Particulate Guanylyl Cyclase and Lowers Cyclic GMP in LLC-PK1 Cells.

Bioscience, biotechnology, and biochemistry

Tanaka T, Ichimura M, Nakajo S, Snajdar RM, Morishita Y, Sano T, Yamada K, Inagami T, Matsuda Y.
PMID: 27286374
Biosci Biotechnol Biochem. 1992 Jan;56(7):1041-5. doi: 10.1271/bbb.56.1041.

HS-142-1, a novel atrial natriuretic peptide (ANP) antagonist isolated from the culture broth of Aureobasidium sp., selectively inhibits ANP-induced cyclic GMP accumulation in porcine kidney epithelial LLC-PK1 cells. At concentrations from 0.1 to 100 μg/ml (= 2.5 × 10(-8)...

Cite
Tanaka T, Ichimura M, Nakajo S, et al. HS-142-1, a Novel Non-peptide Antagonist for Atrial Natriuretic Peptide Receptor, Selectively Inhibits Particulate Guanylyl Cyclase and Lowers Cyclic GMP in LLC-PK1 Cells. Biosci Biotechnol Biochem. 1992;56(7):1041-5doi: 10.1271/bbb.56.1041.
Tanaka, T., Ichimura, M., Nakajo, S., Snajdar, R. M., Morishita, Y., Sano, T., Yamada, K., Inagami, T., & Matsuda, Y. (1992). HS-142-1, a Novel Non-peptide Antagonist for Atrial Natriuretic Peptide Receptor, Selectively Inhibits Particulate Guanylyl Cyclase and Lowers Cyclic GMP in LLC-PK1 Cells. Bioscience, biotechnology, and biochemistry, 56(7), 1041-5. https://doi.org/10.1271/bbb.56.1041
Tanaka, T, et al. "HS-142-1, a Novel Non-peptide Antagonist for Atrial Natriuretic Peptide Receptor, Selectively Inhibits Particulate Guanylyl Cyclase and Lowers Cyclic GMP in LLC-PK1 Cells." Bioscience, biotechnology, and biochemistry vol. 56,7 (1992): 1041-5. doi: https://doi.org/10.1271/bbb.56.1041
Tanaka T, Ichimura M, Nakajo S, Snajdar RM, Morishita Y, Sano T, Yamada K, Inagami T, Matsuda Y. HS-142-1, a Novel Non-peptide Antagonist for Atrial Natriuretic Peptide Receptor, Selectively Inhibits Particulate Guanylyl Cyclase and Lowers Cyclic GMP in LLC-PK1 Cells. Biosci Biotechnol Biochem. 1992 Jan;56(7):1041-5. doi: 10.1271/bbb.56.1041. PMID: 27286374.
Copy Download .nbib Format: NLM
Nutritional Requirements in Multiple Auxotrophic Lactic Acid Bacteria: Genetic Lesions Affecting Amino Acid Biosynthetic Pathways in Lactococcus lactis, Enterococcus faecium, and Pediococcus acidilactici.

Bioscience, biotechnology, and biochemistry

Deguchi Y, Morishita T.
PMID: 27280812
Biosci Biotechnol Biochem. 1992 Jan;56(6):913-8. doi: 10.1271/bbb.56.913.

In a study of genetic lesions responsible for amino acid requirements in multiple auxotrophic lactic acid bacteria, a systematic attempt was made to isolate mutants that could synthesize each of the amino acids required by the parental strains of...

Cite
Deguchi Y, Morishita T. Nutritional Requirements in Multiple Auxotrophic Lactic Acid Bacteria: Genetic Lesions Affecting Amino Acid Biosynthetic Pathways in Lactococcus lactis, Enterococcus faecium, and Pediococcus acidilactici. Biosci Biotechnol Biochem. 1992;56(6):913-8doi: 10.1271/bbb.56.913.
Deguchi, Y., & Morishita, T. (1992). Nutritional Requirements in Multiple Auxotrophic Lactic Acid Bacteria: Genetic Lesions Affecting Amino Acid Biosynthetic Pathways in Lactococcus lactis, Enterococcus faecium, and Pediococcus acidilactici. Bioscience, biotechnology, and biochemistry, 56(6), 913-8. https://doi.org/10.1271/bbb.56.913
Deguchi, Y, and Morishita, T. "Nutritional Requirements in Multiple Auxotrophic Lactic Acid Bacteria: Genetic Lesions Affecting Amino Acid Biosynthetic Pathways in Lactococcus lactis, Enterococcus faecium, and Pediococcus acidilactici." Bioscience, biotechnology, and biochemistry vol. 56,6 (1992): 913-8. doi: https://doi.org/10.1271/bbb.56.913
Deguchi Y, Morishita T. Nutritional Requirements in Multiple Auxotrophic Lactic Acid Bacteria: Genetic Lesions Affecting Amino Acid Biosynthetic Pathways in Lactococcus lactis, Enterococcus faecium, and Pediococcus acidilactici. Biosci Biotechnol Biochem. 1992 Jan;56(6):913-8. doi: 10.1271/bbb.56.913. PMID: 27280812.
Copy Download .nbib Format: NLM
A case of a vitreomacular traction-associated macular microhole in an eye with focal choroidal excavation.

Case reports in ophthalmology

Fukumoto M, Morishita S, Okuda Y, Suzuki H, Sato T, Kida T, Ikeda T.
PMID: 25802509
Case Rep Ophthalmol. 2015 Feb 21;6(1):71-5. doi: 10.1159/000377667. eCollection 2015.

PURPOSE: It was the aim of this study to report a case of a vitreomacular traction-associated macular microhole (MMH) in an eye with focal choroidal excavation (FCE) detected by spectral-domain optical coherence tomography (SD-OCT).PATIENTS AND METHODS: A 38-year-old Japanese...

Cite
Fukumoto M, Morishita S, Okuda Y, et al. A case of a vitreomacular traction-associated macular microhole in an eye with focal choroidal excavation. Case Rep Ophthalmol. 2015;6(1):71-5doi: 10.1159/000377667.
Fukumoto, M., Morishita, S., Okuda, Y., Suzuki, H., Sato, T., Kida, T., & Ikeda, T. (2015). A case of a vitreomacular traction-associated macular microhole in an eye with focal choroidal excavation. Case reports in ophthalmology, 6(1), 71-5. https://doi.org/10.1159/000377667
Fukumoto, Masanori, et al. "A case of a vitreomacular traction-associated macular microhole in an eye with focal choroidal excavation." Case reports in ophthalmology vol. 6,1 (2015): 71-5. doi: https://doi.org/10.1159/000377667
Fukumoto M, Morishita S, Okuda Y, Suzuki H, Sato T, Kida T, Ikeda T. A case of a vitreomacular traction-associated macular microhole in an eye with focal choroidal excavation. Case Rep Ophthalmol. 2015 Feb 21;6(1):71-5. doi: 10.1159/000377667. eCollection 2015. PMID: 25802509; PMCID: PMC4357680.
Copy Download .nbib Format: NLM
Measurement of serum and vitreous concentrations of anti-type II collagen antibody in diabetic retinopathy.

Clinical ophthalmology (Auckland, N.Z.)

Nakaizumi A, Fukumoto M, Kida T, Suzuki H, Morishita S, Satou T, Oku H, Ikeda T, Nakamura K.
PMID: 25848204
Clin Ophthalmol. 2015 Mar 20;9:543-7. doi: 10.2147/OPTH.S75422. eCollection 2015.

BACKGROUND: Autoimmune mechanisms have been postulated as a cause of diabetic retinopathy (DR), as several autoantibodies have reportedly been detected in the serum of DR patients. In this present study, we measured serum and vitreous levels of anti-type II...

Cite
Nakaizumi A, Fukumoto M, Kida T, et al. Measurement of serum and vitreous concentrations of anti-type II collagen antibody in diabetic retinopathy. Clin Ophthalmol. 2015;9:543-7doi: 10.2147/OPTH.S75422.
Nakaizumi, A., Fukumoto, M., Kida, T., Suzuki, H., Morishita, S., Satou, T., Oku, H., Ikeda, T., & Nakamura, K. (2015). Measurement of serum and vitreous concentrations of anti-type II collagen antibody in diabetic retinopathy. Clinical ophthalmology (Auckland, N.Z.), 9543-7. https://doi.org/10.2147/OPTH.S75422
Nakaizumi, Atsuko, et al. "Measurement of serum and vitreous concentrations of anti-type II collagen antibody in diabetic retinopathy." Clinical ophthalmology (Auckland, N.Z.) vol. 9 (2015): 543-7. doi: https://doi.org/10.2147/OPTH.S75422
Nakaizumi A, Fukumoto M, Kida T, Suzuki H, Morishita S, Satou T, Oku H, Ikeda T, Nakamura K. Measurement of serum and vitreous concentrations of anti-type II collagen antibody in diabetic retinopathy. Clin Ophthalmol. 2015 Mar 20;9:543-7. doi: 10.2147/OPTH.S75422. eCollection 2015. PMID: 25848204; PMCID: PMC4376299.
Copy Download .nbib Format: NLM
Vitreous estrogen levels in patients with an idiopathic macular hole.

Clinical ophthalmology (Auckland, N.Z.)

Inokuchi N, Ikeda T, Nakamura K, Morishita S, Fukumoto M, Kida T, Oku H.
PMID: 25848205
Clin Ophthalmol. 2015 Mar 20;9:549-52. doi: 10.2147/OPTH.S80754. eCollection 2015.

PURPOSE: Estrogen, a female hormone, activates collagenase and might be associated with the pathogenesis of vitreoretinal collagen fiber disease. The purpose of the present study was to investigate the vitreous levels of estrone (E1) and estradiol (E2) in subjects...

Cite
Inokuchi N, Ikeda T, Nakamura K, et al. Vitreous estrogen levels in patients with an idiopathic macular hole. Clin Ophthalmol. 2015;9:549-52doi: 10.2147/OPTH.S80754.
Inokuchi, N., Ikeda, T., Nakamura, K., Morishita, S., Fukumoto, M., Kida, T., & Oku, H. (2015). Vitreous estrogen levels in patients with an idiopathic macular hole. Clinical ophthalmology (Auckland, N.Z.), 9549-52. https://doi.org/10.2147/OPTH.S80754
Inokuchi, Naoki, et al. "Vitreous estrogen levels in patients with an idiopathic macular hole." Clinical ophthalmology (Auckland, N.Z.) vol. 9 (2015): 549-52. doi: https://doi.org/10.2147/OPTH.S80754
Inokuchi N, Ikeda T, Nakamura K, Morishita S, Fukumoto M, Kida T, Oku H. Vitreous estrogen levels in patients with an idiopathic macular hole. Clin Ophthalmol. 2015 Mar 20;9:549-52. doi: 10.2147/OPTH.S80754. eCollection 2015. PMID: 25848205; PMCID: PMC4376308.
Copy Download .nbib Format: NLM
A Case of Coats' Disease with Spontaneous Retinal Reattachment after Total Detachment.

Case reports in ophthalmology

Ochi R, Sato B, Mimura M, Morishita S, Fukumoto M, Kida T, Sugasawa J, Ikeda T.
PMID: 26265905
Case Rep Ophthalmol. 2015 Jun 23;6(2):200-3. doi: 10.1159/000434676. eCollection 2015.

PURPOSE: To report a case of Coats' disease in which spontaneous reattachment occurred after total retinal detachment.PATIENT AND METHODS: A young boy (patient age: 4 years and 11 months) presented with leukocoria in the left eye. Slit-lamp examination revealed...

Cite
Ochi R, Sato B, Mimura M, et al. A Case of Coats' Disease with Spontaneous Retinal Reattachment after Total Detachment. Case Rep Ophthalmol. 2015;6(2):200-3doi: 10.1159/000434676.
Ochi, R., Sato, B., Mimura, M., Morishita, S., Fukumoto, M., Kida, T., Sugasawa, J., & Ikeda, T. (2015). A Case of Coats' Disease with Spontaneous Retinal Reattachment after Total Detachment. Case reports in ophthalmology, 6(2), 200-3. https://doi.org/10.1159/000434676
Ochi, Ryosuke, et al. "A Case of Coats' Disease with Spontaneous Retinal Reattachment after Total Detachment." Case reports in ophthalmology vol. 6,2 (2015): 200-3. doi: https://doi.org/10.1159/000434676
Ochi R, Sato B, Mimura M, Morishita S, Fukumoto M, Kida T, Sugasawa J, Ikeda T. A Case of Coats' Disease with Spontaneous Retinal Reattachment after Total Detachment. Case Rep Ophthalmol. 2015 Jun 23;6(2):200-3. doi: 10.1159/000434676. eCollection 2015. PMID: 26265905; PMCID: PMC4519598.
Copy Download .nbib Format: NLM
The combined effects of transcutaneous electrical nerve stimulation (TENS) and stretching on muscle hardness and pressure pain threshold.

Journal of physical therapy science

Karasuno H, Ogihara H, Morishita K, Yokoi Y, Fujiwara T, Ogoma Y, Abe K.
PMID: 27190439
J Phys Ther Sci. 2016 Apr;28(4):1124-30. doi: 10.1589/jpts.28.1124. Epub 2016 Apr 28.

[Purpose] This study aimed to clarify the immediate effects of a combined transcutaneous electrical nerve stimulation and stretching protocol. [Subjects] Fifteen healthy young males volunteered to participate in this study. The inclusion criterion was a straight leg raising range...

Cite
Karasuno H, Ogihara H, Morishita K, et al. The combined effects of transcutaneous electrical nerve stimulation (TENS) and stretching on muscle hardness and pressure pain threshold. J Phys Ther Sci. 2016;28(4):1124-30doi: 10.1589/jpts.28.1124.
Karasuno, H., Ogihara, H., Morishita, K., Yokoi, Y., Fujiwara, T., Ogoma, Y., & Abe, K. (2016). The combined effects of transcutaneous electrical nerve stimulation (TENS) and stretching on muscle hardness and pressure pain threshold. Journal of physical therapy science, 28(4), 1124-30. https://doi.org/10.1589/jpts.28.1124
Karasuno, Hiroshi, et al. "The combined effects of transcutaneous electrical nerve stimulation (TENS) and stretching on muscle hardness and pressure pain threshold." Journal of physical therapy science vol. 28,4 (2016): 1124-30. doi: https://doi.org/10.1589/jpts.28.1124
Karasuno H, Ogihara H, Morishita K, Yokoi Y, Fujiwara T, Ogoma Y, Abe K. The combined effects of transcutaneous electrical nerve stimulation (TENS) and stretching on muscle hardness and pressure pain threshold. J Phys Ther Sci. 2016 Apr;28(4):1124-30. doi: 10.1589/jpts.28.1124. Epub 2016 Apr 28. PMID: 27190439; PMCID: PMC4868199.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1081 entries